S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
GOOGL   1,245.66 (-0.57%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
MU   43.47 (-4.46%)
BABA   170.36 (-3.67%)
TSLA   256.90 (-1.94%)
AMD   30.81 (-1.06%)
T   38.23 (+1.08%)
NFLX   275.30 (-6.15%)
GILD   64.23 (-1.53%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
GOOGL   1,245.66 (-0.57%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
MU   43.47 (-4.46%)
BABA   170.36 (-3.67%)
TSLA   256.90 (-1.94%)
AMD   30.81 (-1.06%)
T   38.23 (+1.08%)
NFLX   275.30 (-6.15%)
GILD   64.23 (-1.53%)
Log in

AngioSoma Stock Price, News & Analysis (NASDAQ:SOAN)

$0.0039
0.00 (0.00 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.04
Volume269,195 shs
Average Volume2.55 million shs
Market Capitalization$664,821.30
P/E RatioN/A
Dividend YieldN/A
BetaN/A
AngioSoma, Inc. operates as a clinical stage biotechnology company. The company's lead drug candidates include Liprostin that completed Phase I and three Phase II clinical trials, and Prostaglandin E1 that completed Phase II clinical trials for the treatment of peripheral artery diseases. It also markets a line of nutraceutical supplements under the SomaCeuticals name. AngioSoma, Inc. was founded in 2016 and is based in Houston, Texas.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SOAN
CUSIPN/A
CIKN/A
Phone832-781-8521

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$664,821.30
Next Earnings DateN/A
OptionableNot Optionable

Receive SOAN News and Ratings via Email

Sign-up to receive the latest news and ratings for SOAN and its competitors with MarketBeat's FREE daily newsletter.


AngioSoma (NASDAQ:SOAN) Frequently Asked Questions

What is AngioSoma's stock symbol?

AngioSoma trades on the NASDAQ under the ticker symbol "SOAN."

Has AngioSoma been receiving favorable news coverage?

News articles about SOAN stock have been trending neutral on Friday, InfoTrie Sentiment reports. The research group scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. AngioSoma earned a news impact score of 0.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for AngioSoma.

Who are some of AngioSoma's key competitors?

Who are AngioSoma's key executives?

AngioSoma's management team includes the folowing people:
  • Ms. Alex K. Blankenship, CEO, Pres, Sec., Treasurer, Principal Exec. Ofc., Principal Fin. & Acc. Ofc. and Director (Age 56)

How do I buy shares of AngioSoma?

Shares of SOAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is AngioSoma's stock price today?

One share of SOAN stock can currently be purchased for approximately $0.00.

How big of a company is AngioSoma?

AngioSoma has a market capitalization of $664,821.30. View Additional Information About AngioSoma.

What is AngioSoma's official website?

The official website for AngioSoma is http://angiosoma.com/.

How can I contact AngioSoma?

The company can be reached via phone at 832-781-8521.


MarketBeat Community Rating for AngioSoma (NASDAQ SOAN)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  22 (Vote Outperform)
Underperform Votes:  27 (Vote Underperform)
Total Votes:  49
MarketBeat's community ratings are surveys of what our community members think about AngioSoma and other stocks. Vote "Outperform" if you believe SOAN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SOAN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: Resistance Level

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel